25 May 2023 – Buckinghamshire, UK
Radcliffe Cardiology, a global community for cardiovascular professionals, today announces a partnership with the International Cardio-Oncology Society (IC-OS), a leading provider of education for HCPs engaged in the cardio-oncology space.
From 1 June, Radcliffe Cardiology will host a free-to-access weekly broadcast featuring opinion leaders from IC-OS’s community with the aim to support HCPs globally protect the cardiovascular health of patients with cancer, enhancing outcomes, survival rates and quality of life. In addition, Radcliffe Cardiology will become the home of IC-OS’s rich catalogue of over 250 on-demand webinars and videos, providing a valuable educational repository for professionals in the field.
Encompassing a range of content formats – including journal clubs and case reviews – and addressing pertinent topics ranging from the cardiovascular effects of radiation therapy to pediatrics and imaging modalities, each broadcast will aim to deepen knowledge and promote collaboration between highly specialized professionals.
The partnership combines Radcliffe’s rapidly growing global community of over 225,000 HCPs and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
Of the agreement David Ramsey, CEO of Radcliffe Group (owner of Radcliffe Cardiology), commented: “Cardiovascular disease and cancer are among the most prevalent diseases globally, and share a number of common conditions – and the burden of both is set to rise. For some time Radcliffe Cardiology has sought to increase its educational offering in this area. There is no better way of achieving this than through this exciting partnership with the International Cardio-Oncology Society.”
Susan Dent, President of IC-OS commented: "At IC-OS our mission is to advance the cardiovascular care of patients with cancer by promoting collaboration among educators, researchers and clinicians around the world. We look forward to this new partnership with Radcliffe as we strive to educate health care providers and enhance patient care globally."
Register for the first IC-OS broadcast on Radcliffe Cardiology now.
For further information regarding this partnership, contact:
-
Jonathan McKenna, Managing Director, Radcliffe Group. E: jonathan.mckenna@radcliffe-group.com
-
Stephen J Casselli, Executive Director. E: directoricos@gmail.com
About Radcliffe Cardiology
Radcliffe Cardiology is a knowledge network for the cardiovascular community. Radcliffe endeavours to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using communications and creative expertise, innovative platforms and connections across the community to help transform theory into practice faster and more effectively. From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, Radcliffe believes that communication is at the heart of great healthcare.
More information on Radcliffe Cardiology
About the International Cardio-Oncology Society
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimizing the cardiac status of patients with cancer before, during and after their treatment, IC-OS are collectively improving the overall outcomes including survival and quality of life. IC-OS aim to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection. IC-OS’s vision is to eliminate cardiovascular disease as a barrier to effective cancer therapy in all of our patients being treated or who were previously treated for cancer. With this in mind, the society is centred around its mission to advance cardiovascular care of cancer patients and survivors by promoting collaboration among researchers, educators and clinicians around the world.